Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Paul Trichelair
Observed names:
P Trichelair,
P. Trichelair,
Trichelair, Paul
Observed institutions:
Microsoft Research Montréal (Canada),
McGill University
OpenAlex ID:
A5044824672
Integrating deep learning CT-scan model, biological and clinical variables to predict severity of COVID-19 patients
2021
·
Nathalie Lassau
, Samy Ammari
, et al.
·
Nature Communications
·
190
PDF
Safe Policy Improvement with Baseline Bootstrapping
2017
·
Laroche, Romain
, Trichelair, Paul
, et al.
·
arXiv (Cornell University)
·
87
PDF
The KnowRef Coreference Corpus: Removing Gender and Number Cues for Difficult Pronominal Anaphora Resolution
2019
·
Ali Emami
, Paul Trichelair
, et al.
·
Annual Meeting of the Association for Computational Linguistics (ACL)
·
43
How Reasonable are Common-Sense Reasoning Tasks: A Case-Study on the Winograd Schema Challenge and SWAG
2019
·
Paul Trichelair
, Ali Emami
, et al.
·
39
External control arm analysis: an evaluation of propensity score approaches, G-computation, and doubly debiased machine learning
2022
·
Nicolas Loiseau
, Paul Trichelair
, et al.
·
BMC Medical Research Methodology
·
29
PDF
Can machine learning bring cardiovascular risk assessment to the next level? A methodological study using FOURIER trial data
2021
·
Adrien Rousset
, David Dellamonica
, et al.
·
European Heart Journal - Digital Health
·
24
PDF
On the Evaluation of Common-Sense Reasoning in Natural Language Understanding.
2018
·
Paul Trichelair
, Ali Emami
, et al.
·
arXiv (Cornell University)
·
10
More efficient and inclusive time-to-event trials with covariate adjustment: a simulation study
2023
·
Raphaëlle Momal
, Honghao Li
, et al.
·
Trials
·
7
PDF
AI-based multi-modal integration of clinical characteristics, lab tests and chest CTs improves COVID-19 outcome prediction of hospitalized patients
2020
·
Lassau, Nathalie
, Ammari, Samy
, et al.
·
HAL (Le Centre pour la Communication Scientifique Directe)
·
3
Abstract 4117032: Investigating the natural history and risk factors underlying deterioration in early-stage hypertrophic cardiomyopathy: findings from SOLENOID
2024
·
William Bradlow
, Kevin Elgui
, et al.
·
Circulation
·
1
Abstract 4138992: Beta blockers and calcium channel blockers in pre-symptomatic patients with hypertrophic cardiomyopathy: prevalence, discontinuation, and effectiveness
2024
·
William Bradlow
, Kevin Elgui
, et al.
·
Circulation
·
1
How Machine Learning Can Enhance Clinical Development
2021
·
P Trichelair
·
Hematological Oncology
·
1
A fully automated machine learning assisted pipeline to predict disease progression for early-stage hypertrophic cardiomyopathy from echocardiography
2026
·
Antoine Olivier
, Auriane Riou
, et al.
·
Frontiers in Cardiovascular Medicine
PDF
1169 OKN4395: a first-in-class highly potent and selective EP2, EP4, and DP1 triple inhibitor for solid cancer treatment alone or in combination with anti-PD1
2025
·
Maximilien Grandclaudon
, Anna Thaller
, et al.
·
Regular and Young Investigator Award Abstracts
PDF
238eP Context-based drug positioning and multimodal characterization for OKN4395
2025
·
A. Grimaldi
, B. Sauty
, et al.
·
Annals of Oncology
Improving risk stratification of recurrent myocardial infarction in a large real-world dataset using machine learning
2023
·
G Chodick
, Z Vered
, et al.
·
European Heart Journal
PDF
More efficient and inclusive time-to-event trials with covariate adjustment: a simulation study
2022
·
Raphaëlle Momal
, Paul Trichelair
, et al.
·
medRxiv
PDF
Show more works
View as search
Works count:
19
Citation count:
435
H-index:
7
I10-index:
7
Year
Topic
Type